Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.4
5.2
Journals
Cancers
Special Issues
Prevention, Diagnosis and Treatment of Oropharyngeal Cancers
share announcement

Prevention, Diagnosis and Treatment of Oropharyngeal Cancers

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".

Deadline for manuscript submissions: closed (20 October 2023) | Viewed by 7877

Special Issue Editors

Dr. Alessandro Villa

E-Mail Website
Guest Editor
1. Oral Medicine, Oral Oncology and Dentistry, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33563, USA
2. Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA
Interests: HPV associated oropharyngeal cancers; oral mucosal diseases; salivary gland disorders
Dr. Noah S. Kalman

E-Mail Website
Co-Guest Editor
Baptist Health Baptist Hospital, Miami, FL 33563, USA
Interests: radiation oncology; cancer

Special Issue Information

Dear Colleagues,

The incidence of oropharyngeal cancer continues to increase. Persistent high-risk human papillomavirus (HPV) infection is the most significant cause of oropharyngeal cancer. Early detection and clinical diagnosis represent an important approach for cancer control. In addition, the advent of the HPV prophylactic vaccine has the potential to reduce the burden of HPV-associated oropharyngeal cancers. The scope of this Special Issue is to improve the understanding of oropharyngeal cancers, including its prevention, diagnosis and treatment. 

Dr. Alessandro Villa
Dr. Noah S. Kalman
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • human papilloma virus
  • oropharyngeal cancers
  • treatment
  • oral complications from cancer therapy
  • HPV vaccination

Published Papers (4 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review, Other

12 pages, 6019 KiB  
Article
Transoral Ultrasound in the Outpatient Clinic for the Diagnostic Work-Up of Oropharyngeal Cancer: A Feasibility Study
by Martin Garset-Zamani, Rikke Norling, Christoffer Holst Hahn, Tina Klitmøller Agander, Christian von Buchwald and Tobias Todsen
Cancers 2023, 15(21), 5292; https://0-doi-org.brum.beds.ac.uk/10.3390/cancers15215292 - 4 Nov 2023
Cited by 2 | Viewed by 1196
Abstract
Magnetic resonance imaging (MRI) is the preferred imaging modality for oropharyngeal cancers (OPCs), but it has difficulties distinguishing between small OPCs and unilateral tonsil hypertrophy. We hypothesized that surgeon-performed transoral ultrasound (US) could be used to accurately detect T-stage OPCs. We performed a [...] Read more.
Magnetic resonance imaging (MRI) is the preferred imaging modality for oropharyngeal cancers (OPCs), but it has difficulties distinguishing between small OPCs and unilateral tonsil hypertrophy. We hypothesized that surgeon-performed transoral ultrasound (US) could be used to accurately detect T-stage OPCs. We performed a single-center prospective diagnostic accuracy study including patients with suspected or biopsy-verified OPCs during outpatient appointments. All patients were offered transoral US and MRI. If transoral US could not be tolerated by the patient, transcervical US was performed. The primary outcome was the diagnostic accuracy of detecting OPCs with US compared to MRI, using histopathology as the reference standard. The secondary outcome was comparing the primary tumor diameters between US and MRI blinded to each other. Out of the 26 patients included in the study, 21 (81%) had OPCs. Transoral US could be performed in 21/21 and 1/5 patients with suspected palatine and lingual tonsil OPCs, respectively. Overall, US diagnostic accuracy was 92%, compared to 81% with MRI (p = 0.37). US and MRI had a high correlation between tumor diameters in the anteroposterior diameter (R = 0.80, p < 0.001), corresponding to the depth axis on US. In conclusion, this small study showed the promise and feasibility of transoral US to improve the initial clinical evaluations of patients with suspected OPCs. Full article
(This article belongs to the Special Issue Prevention, Diagnosis and Treatment of Oropharyngeal Cancers)
►▼ Show Figures

Graphical abstract

Review

Jump to: Research, Other

16 pages, 320 KiB  
Review
Oral Complications from Oropharyngeal Cancer Therapy
by Vidya Sankar and Yuanming Xu
Cancers 2023, 15(18), 4548; https://0-doi-org.brum.beds.ac.uk/10.3390/cancers15184548 - 14 Sep 2023
Viewed by 1182
Abstract
Post-oropharyngeal cancer treatment complications include a multitude of oral side effects that impact overall survival and quality of life. These include acute and chronic conditions affecting the oral cavity and head and neck, such as mucositis, infection, xerostomia, dysgeusia, radiation caries, osteonecrosis, and [...] Read more.
Post-oropharyngeal cancer treatment complications include a multitude of oral side effects that impact overall survival and quality of life. These include acute and chronic conditions affecting the oral cavity and head and neck, such as mucositis, infection, xerostomia, dysgeusia, radiation caries, osteonecrosis, and trismus. This review will summarize the most common oral complications from oropharyngeal cancer therapy. The authors would like to point out that the literature cited frequently combines oropharyngeal and head and neck cancer results. If recommendations are made strictly related to oropharyngeal cancers, this will be highlighted. Full article
(This article belongs to the Special Issue Prevention, Diagnosis and Treatment of Oropharyngeal Cancers)
14 pages, 1965 KiB  
Review
Human Papillomavirus-Associated Oropharyngeal Cancer: Global Epidemiology and Public Policy Implications
by Sifon Ndon, Amritpal Singh, Patrick K. Ha, Joyce Aswani, Jason Ying-Kuen Chan and Mary Jue Xu
Cancers 2023, 15(16), 4080; https://0-doi-org.brum.beds.ac.uk/10.3390/cancers15164080 - 13 Aug 2023
Cited by 3 | Viewed by 1801
Abstract
Global trends in human papillomavirus (HPV)-associated head and neck cancers (HNC), specifically in the oropharynx subsite, have been dynamically changing, leading to new staging and treatment paradigms. Epidemiologic studies have noted regional variations in HPV-associated oropharyngeal squamous cell carcinoma (OPSCC). While HPV vaccination [...] Read more.
Global trends in human papillomavirus (HPV)-associated head and neck cancers (HNC), specifically in the oropharynx subsite, have been dynamically changing, leading to new staging and treatment paradigms. Epidemiologic studies have noted regional variations in HPV-associated oropharyngeal squamous cell carcinoma (OPSCC). While HPV vaccination remains the main preventative approach, vaccination policy in relation to gender neutrality is heterogeneous and particularly sparse in low- and middle-income countries, where the burden of global cancer cases and HPV-associated HNC are not well-characterized in certain regions. This review summarizes the existing literature on regional variations of HPV-associated OPSCC and gender-neutral vaccine policies. Based on available data, the incidence of HPV-associated OPSCC is highest in North America, Europe, and Oceania. As of 2022, 122 of 195 (63%) World Health Organization (WHO) member states had incorporated HPV vaccinations nationally; of these, 41 of 122 (34%) member states have introduced gender-neutral vaccine coverage. Future research is needed to describe continued evolving trends in HPV-associated OPSCC, understand underlying risk factors leading to regional variation in disease, and implement gender-neutral policy more broadly. Full article
(This article belongs to the Special Issue Prevention, Diagnosis and Treatment of Oropharyngeal Cancers)
►▼ Show Figures

Graphical abstract

Other

Jump to: Research, Review

49 pages, 1457 KiB  
Systematic Review
Oral Human Papillomavirus Benign Lesions and HPV-Related Cancer in Healthy Children: A Systematic Review
by Federica Di Spirito, Giuseppe Pantaleo, Maria Pia Di Palo, Alessandra Amato, Annunziata Raimondo and Massimo Amato
Cancers 2023, 15(4), 1096; https://0-doi-org.brum.beds.ac.uk/10.3390/cancers15041096 - 8 Feb 2023
Cited by 13 | Viewed by 3159
Abstract
The present systematic review aimed to assess the prevalence of oral HPV-related lesions, categorized as benign (verruca vulgaris “VV”, squamous cell papilloma “SP”, condyloma acuminata “CA”, and focal epithelial hyperplasia “FEH”) and malignant (oral squamous cell carcinoma “OSCC”), in descending order of occurrence [...] Read more.
The present systematic review aimed to assess the prevalence of oral HPV-related lesions, categorized as benign (verruca vulgaris “VV”, squamous cell papilloma “SP”, condyloma acuminata “CA”, and focal epithelial hyperplasia “FEH”) and malignant (oral squamous cell carcinoma “OSCC”), in descending order of occurrence in pediatric subjects (≤18 years of age). The secondary objectives were to evaluate the frequency and types of oral lesions described in relation to HPV genotypes and the HPV vaccine type (if any). The study protocol, compliant with the PRISMA statement, was registered at PROSPERO (CRD42022352268). Data from 60 studies, of which quality was assessed using the ROBINS-I tool, were independently extracted and synthesized. Along with seven poorly described benign HPV-related oral lesions that could not be categorized, a total of 146 HPV-related oral lesions, namely 47.26% (n = 69) VV, SP, and CA, 51.37% (n = 75) FEH, and 1.37% (n = 2) OSSC, were diagnosed in 153 pediatric subjects (M:F ratio = 1:1.4) with a mean age of lesion onset of 8.46 years. The viral genotypes detected were HPV-13 (30.61%), -6 (20.41%), -11 (16.33%), HPV-2 (12.24%), -32 (10.20%), -57 (6.12%), and -16 (4.08%). No HPV vaccination was reported in any case. Further studies should be conducted to evaluate the prevalence of HPV-related benign and malignant lesions and the potential role of HPV and associated vaccination in oral carcinogenesis in pediatric subjects. Full article
(This article belongs to the Special Issue Prevention, Diagnosis and Treatment of Oropharyngeal Cancers)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-4
Back to TopTop